TickerFactsScreenerDevelopers

CNBX Pharmaceuticals Inc. (CNBX) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $02013: $02014: $98.8K2015: $25.2K2016: $19.1K2017: $1.39M2018: $1.39M2019: $266.0K2020: $777.6K2021: $1.39M2022: $117.5K2023: $129.7K2024: $26.4K2025: $15.1K$15.1K
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$15.1K-42.8%
2024$26.4K-79.6%
2023$129.7K+10.4%
2022$117.5K-91.5%
2021$1.39M+78.3%
2020$777.6K+192.4%
2019$266.0K-80.9%
2018$1.39M+0.0%
2017$1.39M+7186.1%
2016$19.1K-24.2%
2015$25.2K-74.5%
2014$98.8K—
2013$0—
2012$0—